BAFF levels rise during immune responses, and fecal BAFF exhibits high sensitivity (85%–90%) in differentiating IBD from healthy samples, surpassing serum BAFF, which has a sensitivity range of 50%–64%.78 This evidence concerns the gene TNFSF13B and inflammatory bowel disease.